<DOC>
	<DOCNO>NCT02823912</DOCNO>
	<brief_summary>The increase mortality cardiovascular disease significant impact population , prevalence diseases become one major problem , since lead cause mortality 1 3 Mexicans suffer cardiovascular disease accord ENSANUT ; attribute increase disease associated inflammatory process accelerate obesity , dyslipidemia , hypertension ( SAH ) diabetes mellitus ( DM ) . The cholesterol major risk factor development cardiovascular disease , turn increase chance death ; however , treatment choice base change lifestyle , people difficult maintain long-term . As drug therapy treat drug many people achieve therapeutic goal , therefore inflammatory condition underlies disease remain . Recent study focus possible role capsaicin inflammatory state agonistic effect TRPV1 . It demonstrate antiinflammatory activity capsaicin enhance inflammation free fatty acid ( FFA ) reduce expression certain gene involve process induce . Capsaicin natural choice well tolerated side effect limit gastrointestinal tract dyspepsia intestinal irregularity , interest evaluate effect capsaicin profile inflammatory cytokine individual dyslipidemia .</brief_summary>
	<brief_title>Capsaicin Effect Cytokines Profile Dyslipidemia</brief_title>
	<detailed_description>It conduct clinicala trial , double - blind , randomize placebo control group . Female male patient , dyslipidemia . Two group form 17 patient ( capsaicin 150 mg per day Magnesia calcinada ) . At begin end intervention clinical laboratory determination . The data obteined analyzed use SPSS statistical software version 22 . It consider statistically significant p &lt; 0.05</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>diagnosis dyslipidemia time screen BMI 25 kg /m2 34.9 kg / m2 Without drug treatment last three month Signature consent information write Pregnant lactate Total cholesterol ≥ 239 mg / dL , ≥400 TG , LDLC ≥139 Other inflammatory disease consumption type supplement Diagnosis history kidney liver disease ∞ History hypersensitivity compound use study</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Capsaicin</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Inflammatory cytokine</keyword>
</DOC>